Deryugina EI - Search Results

1

The cell surface glycoprotein CDCP1 in cancer--insights, opportunities, and challenges.

Wortmann A, He Y, Deryugina EI, Quigley JP, Hooper JD. Wortmann A, et al. Among authors: deryugina ei. IUBMB Life. 2009 Jul;61(7):723-30. doi: 10.1002/iub.198. IUBMB Life. 2009. PMID: 19514048 Free article. Review.

2

Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma.

Kryza T, Khan T, Puttick S, Li C, Sokolowski KA, Tse BW, Cuda T, Lyons N, Gough M, Yin J, Parkin A, Deryugina EI, Quigley JP, Law RHP, Whisstock JC, Riddell AD, Barbour AP, Wyld DK, Thomas PA, Rose S, Snell CE, Pajic M, He Y, Hooper JD. Kryza T, et al. Among authors: deryugina ei. Theranostics. 2020 Mar 4;10(9):4116-4133. doi: 10.7150/thno.43589. eCollection 2020. Theranostics. 2020. PMID: 32226543 Free PMC article.

3

Functional role of cell surface CUB domain-containing protein 1 in tumor cell dissemination.

Deryugina EI, Conn EM, Wortmann A, Partridge JJ, Kupriyanova TA, Ardi VC, Hooper JD, Quigley JP. Deryugina EI, et al. Mol Cancer Res. 2009 Aug;7(8):1197-211. doi: 10.1158/1541-7786.MCR-09-0100. Epub 2009 Aug 11. Mol Cancer Res. 2009. PMID: 19671673 Free PMC article.

4

Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells.

Casar B, He Y, Iconomou M, Hooper JD, Quigley JP, Deryugina EI. Casar B, et al. Among authors: deryugina ei. Oncogene. 2012 Aug 30;31(35):3924-38. doi: 10.1038/onc.2011.555. Epub 2011 Dec 19. Oncogene. 2012. PMID: 22179830 Free PMC article.

5

Inhibition of tumor metastasis: functional immune modulation of the CUB domain containing protein 1.

Fukuchi K, Steiniger SC, Deryugina E, Liu Y, Lowery CA, Gloeckner C, Zhou B, Kaufmann GF, Quigley JP, Janda KD. Fukuchi K, et al. Mol Pharm. 2010 Feb 1;7(1):245-53. doi: 10.1021/mp900236t. Mol Pharm. 2010. PMID: 19916495 Free PMC article.

6

In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.

Casar B, Rimann I, Kato H, Shattil SJ, Quigley JP, Deryugina EI. Casar B, et al. Among authors: deryugina ei. Oncogene. 2014 Jan 9;33(2):255-68. doi: 10.1038/onc.2012.547. Epub 2012 Dec 3. Oncogene. 2014. PMID: 23208492 Free PMC article.

7

Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions.

Deryugina EI, Quigley JP. Deryugina EI, et al. Biochim Biophys Acta. 2010 Jan;1803(1):103-20. doi: 10.1016/j.bbamcr.2009.09.017. Epub 2009 Oct 2. Biochim Biophys Acta. 2010. PMID: 19800930 Free PMC article. Review.

8

Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist-Treated Prostate Cancers.

Maxwell PJ, McKechnie M, Armstrong CW, Manley JM, Ong CW, Worthington J, Mills IG, Longley DB, Quigley JP, Zoubeidi A, de Bono JS, Deryugina E, LaBonte MJ, Waugh DJJ. Maxwell PJ, et al. Mol Cancer Res. 2022 Jun 3;20(6):841-853. doi: 10.1158/1541-7786.MCR-21-0780. Mol Cancer Res. 2022. PMID: 35302608 Free PMC article.

9

Matrix metalloproteinases and tumor metastasis.

Deryugina EI, Quigley JP. Deryugina EI, et al. Cancer Metastasis Rev. 2006 Mar;25(1):9-34. doi: 10.1007/s10555-006-7886-9. Cancer Metastasis Rev. 2006. PMID: 16680569 Review.

10

Cell surface proteomics identifies molecules functionally linked to tumor cell intravasation.

Conn EM, Madsen MA, Cravatt BF, Ruf W, Deryugina EI, Quigley JP. Conn EM, et al. Among authors: deryugina ei. J Biol Chem. 2008 Sep 26;283(39):26518-27. doi: 10.1074/jbc.M803337200. Epub 2008 Jul 24. J Biol Chem. 2008. PMID: 18658134 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page